Suppr超能文献

30 年单中心动脉型胸廓出口综合征经验。

Thirty-year single-center experience with arterial thoracic outlet syndrome.

机构信息

Division of Vascular Surgery, University of Rochester Medical Center, Rochester, NY.

Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.

出版信息

J Vasc Surg. 2022 Aug;76(2):523-530. doi: 10.1016/j.jvs.2022.03.870. Epub 2022 Apr 1.

Abstract

OBJECTIVE

Arterial thoracic outlet syndrome (ATOS) is rare. We present our 30-year experience with the management of ATOS at a high-volume referral center.

METHODS

A retrospective review of all patients who had undergone primary operative treatment for ATOS from 1988 to 2018 was performed. ATOS was defined as subclavian artery pathology caused by extrinsic compression from a bony abnormality within the thoracic outlet.

RESULTS

A total of 41 patients (45 limbs) underwent surgery for ATOS at a median age of 46 years (interquartile range [IQR], 34-58 years). Chronic symptoms (>6 weeks) were present in 31 limbs (69%). Of the 45 limbs, 13 (29%) presented with acute limb ischemia (ALI), requiring urgent brachial artery thromboembolectomy (BAT) in 9 and catheter-directed thrombolysis and thrombectomy (CDT) in 4. All patients underwent thoracic outlet decompression. 31 limbs (69%) required subclavian artery reconstruction. No perioperative deaths and only one major adverse limb event occurred. Patients with ALI underwent staged thoracic outlet decompression after initial BAT or CDT at a median of 23 days (IQR, 11-140 days). Of the 13 limbs with an initial presentation of ALI, 8 (62%) had recurrent thromboembolic events before thoracic outlet decompression subsequently requiring 10 additional BATs and 1 CDT. The cumulative probability of recurrent embolization at 14, 30, and 90 days was 8.33% (95% confidence interval [CI], 1.28%-54.42%), 16.67% (95% CI, 4.70%-59.06%), and 33.33% (95% CI, 14.98-74.20%), respectively. The median follow-up for 32 patients (35 limbs) was 13 months (IQR, 5-36 months). Subclavian artery/graft primary and secondary patency was 87% and 90%, respectively, at 5 years by Kaplan-Meier analysis. Of the 35 limbs, 5 (14%) had chronic upper extremity pain and 5 (14%) had persistent weakness. Preoperative forearm or hand pain and brachial artery occlusion were associated with chronic pain (P = .04 and P = .03) and weakness (P = .03 and P = .02). Of the 13 limbs that presented with ALI, 11 had a median follow-up after thoracic outlet decompression of 6 months (IQR, 5-14 months), including 9 (82%) with oral anticoagulation therapy. Anticoagulation therapy had no effect on subclavian artery patency (P = 1.0) or the presence of chronic symptoms (P = .93).

CONCLUSIONS

The presentation of ATOS is diverse, and the diagnosis can be delayed. Preoperative upper extremity pain and brachial artery occlusion in the setting of ALI were associated with chronic pain and weakness after thoracic outlet decompression. Delayed thoracic outlet decompression was associated with an increased risk of recurrent thromboembolic events for patients who presented with ALI. An early and accurate diagnosis of ATOS is necessary to reduce morbidity and optimize outcomes.

摘要

目的

胸廓出口综合征(arterial thoracic outlet syndrome,ATOS)较为罕见。我们在一家高容量转诊中心报告了 30 年来对 ATOS 进行管理的经验。

方法

对 1988 年至 2018 年间因 ATOS 接受初次手术治疗的所有患者进行了回顾性研究。ATOS 被定义为锁骨下动脉在外出口处的骨异常引起的血管病理学。

结果

共有 41 名患者(45 侧肢体)接受了 ATOS 手术,中位年龄为 46 岁(四分位距 [interquartile range,IQR],34-58 岁)。31 侧肢体(69%)存在慢性症状(>6 周)。45 侧肢体中,13 侧(29%)表现为急性肢体缺血(acute limb ischemia,ALI),其中 9 例需要紧急行肱动脉血栓切除术(brachial artery thromboembolectomy,BAT),4 例需要行导管直接溶栓和血栓切除术(catheter-directed thrombolysis and thrombectomy,CDT)。所有患者均接受了胸廓出口减压术。31 侧肢体(69%)需要锁骨下动脉重建。无围手术期死亡,仅发生 1 例重大不良肢体事件。在初始 BAT 或 CDT 后,13 例有 ALI 初始表现的肢体中有 11 例(85%)接受分期胸廓出口减压术,中位时间为 23 天(IQR,11-140 天)。在 13 例有 ALI 初始表现的肢体中,有 8 例(62%)在随后接受胸廓出口减压术之前出现复发性血栓栓塞事件,需要 10 例额外的 BAT 和 1 例 CDT。14、30 和 90 天时复发性栓塞的累积概率分别为 8.33%(95%置信区间 [confidence interval,CI],1.28%-54.42%)、16.67%(95% CI,4.70%-59.06%)和 33.33%(95% CI,14.98%-74.20%)。32 名患者(35 侧肢体)的中位随访时间为 13 个月(IQR,5-36 个月)。Kaplan-Meier 分析显示,锁骨下动脉/移植物的原发性和继发性通畅率分别为 87%和 90%,5 年时。在 35 侧肢体中,有 5 侧(14%)有慢性上肢疼痛,5 侧(14%)有持续性无力。术前前臂或手部疼痛和肱动脉闭塞与慢性疼痛(P=0.04 和 P=0.03)和无力(P=0.03 和 P=0.02)相关。在 13 例有 ALI 表现的肢体中,有 11 例在接受胸廓出口减压术中位随访 6 个月(IQR,5-14 个月)后,其中 9 例(82%)接受了口服抗凝治疗。抗凝治疗对锁骨下动脉通畅率(P=1.0)或慢性症状的存在(P=0.93)没有影响。

结论

ATOS 的表现多种多样,诊断可能会延迟。在 ALI 中出现的术前上肢疼痛和肱动脉闭塞与胸廓出口减压术后的慢性疼痛和无力有关。延迟的胸廓出口减压与 ALI 患者复发性血栓栓塞事件的风险增加有关。早期和准确的 ATOS 诊断可降低发病率并优化结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验